

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
According to the latest report by IMARC Group, titled “ Diabetes Care Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
” the global diabetes care devices market reached a strong growth in 2021.
Diabetes care devices are the equipment used to determine or monitor blood sugar levels. Commonly utilized instruments include glucometers, ketone, smart insulin pens, and continuous glucose monitors (CGMs), which consist of lancets, sensors, monitors, docking stations, and test plugs that constantly assist in monitoring diabetic conditions. Diabetes care devices are extensively used to analyze and observe diabetes mellitus, a chronic disease that affects the quantity of glucose absorption in the blood. These appliances also aid in accurately identifying and determining the effectiveness of treatment and lowering the instances of hyperglycemia and hypoglycemia. As a result, diabetes care devices find widespread applications in hospitals, home care, diagnostic centers, clinics, etc.
The escalating product demand to treat and manage symptoms and complications, such as kidney and liver failure, respiratory issues, and cardiovascular conditions, is among the primary factors driving the diabetes care devices market. Besides this, the rising need for glucose monitoring and insulin delivery machines for better care and management of diseases is further augmenting the market growth.
Moreover, the introduction of intelligent diabetes care devices integrated with artificial intelligence (AI), machine learning (ML), and the internet of things (IoT) to facilitate remote monitoring of the patients is also catalyzing the global market. Apart from this, the growing popularity of self-monitoring of blood glucose (SMBG) which assist in the appropriate scheduling of food, activity, and medication, is expected to bolster the diabetes care devices market in the coming years.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2022-2027).
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.